Results

Total Results: 326 records

Showing results for "pregnant women".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-disposition-comments.pdf
    June 16, 2022 - In one study, all participants were pregnant women who were patients at an academic health center.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
    April 01, 2015 - 1 Comparative Effectiveness Review Number 150 Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis Executive Summary Background Multiple sclerosis (MS) is a variably debilitating disease characterized by demyelination (deterioration of the protective myelin sheat…
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments.pdf
    December 23, 2023 - Comparator  Placebo  No treatment  Usual care  Other, specify ______________ • Population  Pregnantwomen  Elderly (65 years and older)  Children & adolescents (up to 18 years old)  Co-morbidities
  4. effectivehealthcare.ahrq.gov/products/headaches-pregnancy/research
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - specific populations was updated (pregnancy: topamax can cause fetal harm when administered to a pregnantwomen); and the counseling information concerning eye disorders was updated The published critique … change for topamax (topiramate) specifying that it can cause fetal harm when administered to a pregnantwoman, and the benefits and risks should be considered when administering the drug in women of childbearing
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - specific populations was updated (pregnancy: topamax can cause fetal harm when administered to a pregnantwomen); and the counseling information concerning eye disorders was updated The published critique … change for topamax (topiramate) specifying that it can cause fetal harm when administered to a pregnantwoman, and the benefits and risks should be considered when administering the drug in women of childbearing
  7. effectivehealthcare.ahrq.gov/health-topics/diabetes-and-pregnancy
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-sepsis.pdf
    July 01, 2023 - affected by sepsis, though certain groups such as neonates, young children, pregnant or recently-pregnantwomen, older persons and individuals with underlying chronic conditions are at an elevated risk.2
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
    January 01, 2020 - Whole-Body Vibration Therapy for Osteoporosis Whole-Body Vibration Therapy for Osteoporosis Technical Brief Number 10 Technical Brief Number 10 Whole-Body Vibration Therapy for Osteoporosis Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 G…
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
    March 17, 2020 - EXCLUDE: Individuals with other conditions, pregnant women, post-partum women.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
    December 01, 2017 - We excluded studies in pregnant women, and restricted our synthesis to treatments currently available
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-protocol-amended.pdf
    November 18, 2024 - Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid Intake and Child Growth and Development Outcomes: A Systematic Review Evidence-based Practice Center Systematic Review Protocol Project Title: Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid Intake and Child Growth and Develop…
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
    February 01, 2019 - Nonopioid Pharmacologic Treatments for Chronic Pain Evidence-based Practice Center Systematic Review Protocol Project Title: Nonopioid Pharmacologic Treatments for Chronic Pain I. Background and Objectives for the Systematic Review Understanding Chronic Pain Chronic pain is typically defined as pain l…
  14. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/child-growth-development-outcomes-protocol.pdf
    August 19, 2024 - Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid Intake and Child Growth and Development Outcomes: A Systematic Review Evidence-based Practice Center Systematic Review Protocol Project Title: Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid Intake and Child Growth and Develop…
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/breastfeeding_research-protocol.pdf
    January 01, 2020 - Inform all pregnant women about the benefits and management of breastfeeding. 4.
  16. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - observable for a later start of follow-up.”3 For example, in a study of miscarriage which enrolls pregnantwomen, some patients will be left truncated because “an unknown proportion of the source population … leading the study sample to not accurately reflect the underlying target population, in this example, pregnantwomen at risk for miscarriage.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-206-evidence-summary-sodium-potassium.pdf
    June 01, 2018 - Evidence-Summary-CER-206-Sodium-And-Potassium-Intake-Effects-On-Chronic-Disease-Outcomes-And-Risk Comparative Effectiveness Review Number 206 Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks Evidence Summary Background and Objectives Cardiovascular disease (CVD) and kidney disease1 ar…
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
    March 01, 2013 - 1 Comparative Effectiveness Review Number 96 Primary Care Management of Abnormal Uterine Bleeding Executive Summary Background Abnormal uterine bleeding (AUB) is among the most common gynecologic complaints of reproductive-age women in ambulatory care settings. It is estimated to affect 11 to 13 percent of…
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-draft-report-rob.xlsx
    January 01, 2017 - No No Yes Yes Yes Yes Low No - the effect of a reduction in the n26:n23 LCPUFA ratio in the diet of pregnantwomen and breastfeeding mothers on adipose tissue growth in their infants up to 1 y of age. 14488 Brantsaeter
  20. effectivehealthcare.ahrq.gov/products/mental-health-pregnancy/research

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: